Sun Pharmaceutical Industries Ltd (SUNPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 948699, "name": "Sun Pharma.Inds.", "stock_name": "Sun Pharma.Inds.", "full_name": "Sun Pharmaceutical Industries Ltd", "name_url": "stocks-analysis/sun-pharmainds", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,990.50", "chg": -10.6, "chgp": "-0.53%", "dir": -1, "prev_price": "2,001.10", "mcapval": "482,770.00 Cr", "mcap": "Large Cap", "scripcode": 524715, "symbol": "SUNPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE044A01036", "curr_date": "Jul 31, 03:30 PM", "curr_time": "21:05 PM", "last_traded_at": "Jul 31, 03:30 PM IST", "bse_nse_vol": "51.06 lacs", "exc_status": "Active", "traded_date": "Jul 31, 2026", "traded_date_str": "2026 07 31", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MS", "url": "https://www.marketsmojo.com/mojostocks#!#top10", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Sun Pharmaceutical Industries Ltd Hits All-Time High of Rs 2,021 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-all-time-high-at-rs-2021-4130336", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4130336.png", "date": "2026-07-31 11:47:40", "description": "" }, { "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 2021", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs2021-4129817", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4129817.png", "date": "2026-07-31 09:47:03", "description": "With a steady climb over the past five sessions culminating in a 3.72% gain, Sun Pharmaceutical Industries Ltd reached a fresh 52-week high of Rs 2021 on 31 Jul 2026, underscoring robust price momentum supported by a suite of bullish technical indicators." }, { "title": "P/E at 38.63 vs Industry's 37.11: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-surges-to-new-high-cementing-its-nifty-50-status-4129745", "imagepath": "", "date": "2026-07-31 09:21:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Reflecting Sector Confidence</strong></p>\n <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 38.63, slightly above the Pharmaceuticals & Biotechnology industry average of 37.11. This premium, though not excessive, signals that investors are willing to pay a higher multiple relative to peers, potentially reflecting confidence in the company’s earnings stability and growth prospects. The market capitalisation of Rs 4,82,506.26 crore places it firmly in the large-cap category, underscoring its dominant position within the sector.</p>\n <p>Such a valuation premium often invites scrutiny — <a href=\"https://www.market..." }, { "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 2009.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs-200985-4128228", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4128228.png", "date": "2026-07-30 09:47:24", "description": "With every major technical indicator aligned to the upside, Sun Pharmaceutical Industries Ltd surged to a fresh 52-week high of Rs 2009.85 on 30 Jul 2026, marking a significant milestone in its price momentum journey." }, { "title": "Sun Pharmaceutical Industries Ltd Hits All-Time High of Rs 2,009.7 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-all-time-high-at-rs-200970-4128182", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4128182.png", "date": "2026-07-30 09:36:42", "description": "" }, { "title": "P/E at 38.29 vs Industry's 37.19: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-surges-to-new-high-cementing-nifty-50-status-4128146", "imagepath": "", "date": "2026-07-30 09:21:50", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Reflects Confidence but Warrants Scrutiny</strong></p>\n <p>The P/E ratio of 38.29 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> sits slightly above the sector average of 37.19, indicating a valuation premium of approximately 3%. This premium suggests that investors are willing to pay a bit more for the stock compared to the average pharmaceutical company, possibly due to its large-cap status and market leadership. However, the premium is not excessive, signalling a balanced market view rather than exuberance. The sector itself has seen a mixed set of results, with six companies reporting so far: four posted positive outcomes and two remained flat, w..." }, { "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1993.4", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs19934-4126230", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4126230.png", "date": "2026-07-29 15:36:37", "description": "With every major moving average and key technical indicator signalling strength, Sun Pharmaceutical Industries Ltd surged to a fresh 52-week high of Rs 1993.4 on 29 Jul 2026, marking a significant milestone in its price momentum journey." }, { "title": "Sun Pharmaceutical Industries Ltd Hits All-Time High of Rs 1,991 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-all-time-high-marking-a-significant-milestone-4126215", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4126215.png", "date": "2026-07-29 15:12:48", "description": "" }, { "title": "P/E at 38.05 vs Industry's 36.78: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-4125420", "imagepath": "", "date": "2026-07-29 09:21:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Reflects Confidence Amid Sector Parity</strong></p>\n <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 38.05, slightly above the Pharmaceuticals & Biotechnology industry average of 36.78. This premium, while not extreme, suggests investors are willing to pay a higher multiple for the company’s earnings relative to peers. The market capitalisation of ₹4,76,387.96 crores classifies it firmly as a large-cap stock, reinforcing its stature within the sector.</p>\n <p>This valuation premium may be interpreted as a reflection of the company’s robust fundamentals and market positioning. However, it also raises the quest..." } ], "total": 1228, "sid": "948699", "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699" }, "announcements": [ { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose", "datetime": "09-Dec-2019" }, { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Press Release", "datetime": "06-Nov-2019" }, { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Updates", "datetime": "18-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(31 Jul 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26", "dt": "2026-07-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10", "dt": "2010-11-25", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13", "dt": "2013-07-29", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Valuation Picture: Premium Reflecting Sector Confidence

The current P/E of Sun Pharmaceutical Industries Ltd stands at 38.63, slightly above the Pharmaceuticals & Biotechnology industry average of 37.11. This premium, though not excessive, signals that investors are willing to pay a higher multiple relative to peers, potentially reflecting confidence in the company’s earnings stability and growth prospects. The market capitalisation of Rs 4,82,506.26 crore places it firmly in the large-cap category, underscoring its dominant position within the sector.

Such a valuation premium often invites scrutiny — Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 2009.85

2026-07-30 09:47:24

With every major technical indicator aligned to the upside, Sun Pharmaceutical Industries Ltd surged to a fresh 52-week high of Rs 2009.85 on 30 Jul 2026, marking a significant milestone in its price momentum journey.

Read full news article

Sun Pharmaceutical Industries Ltd Hits All-Time High of Rs 2,009.7 as Momentum Builds Across Timeframes

2026-07-30 09:36:42

Read full news article

P/E at 38.29 vs Industry's 37.19: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-30 09:21:50

Valuation Picture: Premium Reflects Confidence but Warrants Scrutiny

The P/E ratio of 38.29 for Sun Pharmaceutical Industries Ltd sits slightly above the sector average of 37.19, indicating a valuation premium of approximately 3%. This premium suggests that investors are willing to pay a bit more for the stock compared to the average pharmaceutical company, possibly due to its large-cap status and market leadership. However, the premium is not excessive, signalling a balanced market view rather than exuberance. The sector itself has seen a mixed set of results, with six companies reporting so far: four posted positive outcomes and two remained flat, w...

Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1993.4

2026-07-29 15:36:37

With every major moving average and key technical indicator signalling strength, Sun Pharmaceutical Industries Ltd surged to a fresh 52-week high of Rs 1993.4 on 29 Jul 2026, marking a significant milestone in its price momentum journey.

Read full news article

Sun Pharmaceutical Industries Ltd Hits All-Time High of Rs 1,991 as Momentum Builds Across Timeframes

2026-07-29 15:12:48

Read full news article

P/E at 38.05 vs Industry's 36.78: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-29 09:21:11

Valuation Picture: Premium Reflects Confidence Amid Sector Parity

The current P/E of Sun Pharmaceutical Industries Ltd stands at 38.05, slightly above the Pharmaceuticals & Biotechnology industry average of 36.78. This premium, while not extreme, suggests investors are willing to pay a higher multiple for the company’s earnings relative to peers. The market capitalisation of ₹4,76,387.96 crores classifies it firmly as a large-cap stock, reinforcing its stature within the sector.

This valuation premium may be interpreted as a reflection of the company’s robust fundamentals and market positioning. However, it also raises the quest...

Read full news article

View All News